Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GEL_RobertRyan_BIOMERIT.RR.20100719.01

ABSTRACT: Characterisation of bacterial populations in sputum from cystic fibrosis patients

PROVIDER: PRJEB4820 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR358169.fastq.gz	Fastqsanger.gz
	ERR358170.fastq.gz	Fastqsanger.gz
	ERR358171.fastq.gz	Fastqsanger.gz
	ERR358172.fastq.gz	Fastqsanger.gz
	ERR358173.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 11

Similar Datasets

Transcription profiling by array of Pseudomonas aeruginosa wild-type and phhR mutants grown in a defined synthetic cystic fibrosis sputum medium with and without aromatic amino acids

Project description:Arrays comparing Pseudomonas aeruginosa growth in a defined synthetic cystic fibrosis sputum medium with and without aromatic amino acids. Additional arrays comparing wild-type Pseudomonas aeruginosa and phhR mutant P. aeruginosa in defined synthetic cystic fibrosis sputum medium.

2010-04-01 | E-MEXP-2593 | biostudies-arrayexpress

Single Cell sequencing of human Sputum cells in cystic fibrosis and healthy controls

Project description:The study aimed to compare the gene expression profiles at a single cell level in Sputum cells between patients with cystic fibrosis (CF) and disease controls (CTRL).

2020-07-01 | GSE145360 | GEO

Transcription profiling of Burkholderia cepacia grown in cystic fibrosis sputum

Project description:Transcriptome profile of B. cenocepacia grown in cystic fibrosis sputum

2008-01-01 | E-MEXP-1261 | biostudies-arrayexpress

human lung metagenome

Project description:Sputum samples from cystic fibrosis patients Metagenome

| PRJNA316056 | ENA

Transcription profiling of Pseudomonas aeruginosa PA14 grown in aerobic or anaerobic conditions in cystic fibrosis sputum with added nitrate

Project description:Effect of anaerobic growth condition on gene expression profile of Pseudomonas aeruginosa PA14 grown in cystic fibrosis sputum with 100 mM nitrate added

2007-06-01 | E-MEXP-1051 | biostudies-arrayexpress

In vivo proteome of Pseudomonas aeruginosa in airways of cystic fibrosis patients

Project description:Chronic airway infection with P. aeruginosa (PA) is a hallmark of cystic fibrosis (CF) disease. The mechanisms producing PA persistence in CF therapies remain poorly understood. To gain insight on PA physiology in patient airways and better understand how in vivo bacterial functioning differs from in vitro conditions, we investigated the in vivo proteomes of PA in 35 sputum samples from 11 CF patients. We developed a novel bacterial-enrichment method enabling improved identification of PA proteome with CF sputum samples. The in vivo PA proteomes were compared with the proteomes of ex vivo-grown PA populations from the same patient sample. We detected 1528 PA proteins (encoded by 1458 core genes and 70 accessory genes) that were expressed in CF airways, of which 1178 proteins were commonly identified with the ex vivo-grown PA populations. Label-free quantitation and proteome comparison revealed the in vivo up-regulation of siderophore TonB-dependent receptors, remodeling in central carbon metabolism including glyoxylate cycle and lactate utilization, and alginate overproduction. Knowledge of these in vivo proteome differences or others derived using the presented methodology could lead to future treatment strategies aimed at altering PA physiology in vivo to compromise infectivity or improve antibiotic efficacy.

2019-05-09 | PXD011792 | Pride

Pseudomonas aeruginosa gene expression in artificial sputum medium using a broad capture array designated the PANarray

Project description:The PANarray design (GPL13324) contains the genes of eight P. aeruginosa genomes in non-redundant format, thus allowing identification of expression of non-PAO1 and other P. aeruginosa genes. For the series GSE28152, isogenic isolates were sequentially collected from two cystic fibrosis (CF) patients several years apart. The isolates had not been eradicated in the meantime and represent persister strains. One was an Australian Epidemic Strain-1 isolate and the other a non-epidemic strain. Strains were cultured in an artificial sputum medium (ASMDM) closely resembling CF sputum.

2011-07-15 | E-GEOD-28152 | biostudies-arrayexpress

In vitro evolution of Pseudomonas aeruginosa AA2 biofilms in the presence of cystic fibrosis lung microbiome members

Project description:P. aeruginosa was cultured in a MultiScreen-Mesh plate, which has a filter at the bottom of the wells. The plate was immersed in either in medium alone (control) or in medium inoculated with a mixture of five bacterial strains commonly found in cystic fibrosis sputum (\"microbiome\"). The filter prevented physical contact between P. aeruginosa and the other bacteria, yet soluble products could migrate through the filter into the P. aeruginosa biofilm. P. aeruginosa was then allowed to form biofilms in the wells for 72h, then the biofilm was harvested and a fraction of the harvested cells were used for re-inoculations. This was repeated for 18 cycles for a total of 54 days.

2019-09-13 | E-MTAB-7331 | biostudies-arrayexpress

Characterisation of the Microbiota of Sputum Samples Derived from Cystic Fibrosis Patients at Different Centres

Project description:The aim of this study is to characterise and compare the composition of the microbiota from sputum samples of cystic fibrosis sufferers from different centres. These data are part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/

2014-09-16 | E-ERAD-265 | biostudies-arrayexpress